Górniak, A.; Czapor-Irzabek, H.; Złocińska, A.; Gawin-Mikołajewicz, A.; Karolewicz, B.
Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders. Pharmaceutics 2023, 15, 603.
https://doi.org/10.3390/pharmaceutics15020603
AMA Style
Górniak A, Czapor-Irzabek H, Złocińska A, Gawin-Mikołajewicz A, Karolewicz B.
Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders. Pharmaceutics. 2023; 15(2):603.
https://doi.org/10.3390/pharmaceutics15020603
Chicago/Turabian Style
Górniak, Agata, Hanna Czapor-Irzabek, Adrianna Złocińska, Agnieszka Gawin-Mikołajewicz, and Bożena Karolewicz.
2023. "Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders" Pharmaceutics 15, no. 2: 603.
https://doi.org/10.3390/pharmaceutics15020603
APA Style
Górniak, A., Czapor-Irzabek, H., Złocińska, A., Gawin-Mikołajewicz, A., & Karolewicz, B.
(2023). Screening of Fenofibrate-Simvastatin Solid Dispersions in the Development of Fixed-Dose Formulations for the Treatment of Lipid Disorders. Pharmaceutics, 15(2), 603.
https://doi.org/10.3390/pharmaceutics15020603